Health Promotion and Disease Prevention Research Center

摘要 乳腺癌和宫颈癌很常见，是妇女癌症相关死亡率的主要原因。 低收入和少数族裔的乳腺癌和宫颈癌筛查率特别低 人口数量。美国疾病控制和预防中心全国乳腺癌和宫颈癌早期 检测计划（NBCCEDP）旨在通过提供乳房和宫颈检查来解决这些差异。 通过直接筛查服务和社区临床联系进行癌症筛查 (CCL)采取干预措施，将未经筛查和难以接触的妇女群体与高质量的 筛选服务。我们将系统地确定目前使用的两到三种有前途的CCL干预措施 NBCCEDP受资助者（Grantees）。在CDC评估框架的指导下，我们将与 选定的受助人实施有前途的CCL，以实施严格的有效性和成本效益 评估以确定CCL干预措施在多大程度上增加了未筛查人群的筛查， 很难到达人群。我们还将评估CCL干预措施的可扩展性。我们的发现将 提供有关CCL干预措施关键组成部分的证据，并为未来的规模扩大提出干预措施 并推广以减轻乳腺癌和宫颈癌筛查的负担。

SUMMARY ABSTRACT Breast and cervical cancer are common and contribute significantly to cancer-related mortality for women. Rates of breast and cervical cancer screening are particularly low among low income and minority populations. The Centers for Disease Control and Preventions National Breast and Cervical Cancer Early Detection Program (NBCCEDP) aims to address these disparities by providing access for breast and cervical cancer screening through direct screening services and through implementation of community clinical linkage (CCL) interventions to connect unscreened and difficult to reach populations of women to high quality screening services. We will systematically identify two to three promising CCL interventions currently in use by NBCCEDP Grantees (Grantees). Guided by the CDC Evaluation Framework we will partner with the selected Grantees implementing promising CCLs to implement rigorous effectiveness and cost- effectiveness evaluations to determine the degree to which CCL interventions increase screening among unscreened and difficult to reach populations. We will also assess the scalability of the CCL interventions. Our findings will provide evidence about key components of CCL interventions, and suggest interventions for future scale-up and spread to reduce the burden of breast and cervical cancer screening.